Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × sugemalimab × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Tumor-Agnostic 1

Conditions

Neoplasm, Residual 1

Interventions

pembrolizumab 22 Specimen Handling 18 Magnetic Resonance Spectroscopy 16 Blood Specimen Collection 16 Biopsy 14 Standard of Care 8 Radiosurgery 8 atezolizumab 7 Surveys and Questionnaires 7 Radiotherapy 7 Gemcitabine 7 Cisplatin 7 Paclitaxel 6 Nivolumab 6 Fluorouracil 6 Carboplatin 6 Palliative Care 5 Irinotecan 5 Interviews as Topic 5 Drug Therapy 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 fludarabine 4 durvalumab 4 Taxes 4 Surgical Procedures, Operative 4 Oxaliplatin 4 Observation 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05623267 2023-08-07

SURPASS

Sun Yat-sen University

Phase 2/3 Recruiting

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡